For citations:
Vishneva E.A., Namazova-Baranova L.S., Dobrynina E.A., Alekseeva A.A., Smirnov V.I., Levina J.G., Kalugina V.G., Efendieva K.E., Volkov K.S. The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry. Pediatric pharmacology. 2018;15(2):149-158. (In Russ.) https://doi.org/10.15690/pf.v15i2.1877
Email this article 